Coloplast drops prior skepticism, agrees to divulge national tax information

After having taken a skeptical position on disclosing how much money Coloplast makes in each country where it operates, the company has now shifted its stance on the matter. Effective from the annual report's release in November, Denmark's largest medical technology company will be more transparent about its tax payments.

Photo: Jacob Ehrbahn/Politiken/Ritzau Scanpix

Denmark's second-largest life science company, Coloplast, will henceforth provide both investors and the general public more insight on where the group pays tax, shows the third-quarter financial statement for its fiscal 2021, published Thursday morning.

Upon presenting the annual report for this financial year, set for release on Nov. 1, Coloplast will publish an overview of tax payments in the countries where the company does business.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Sanofi reduces US insulin prices for the uninsured

While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.

Further reading

Related articles

Latest news

See all jobs